What is the Impact Factor of Drugs in Research & Development?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Drugs in Research & Development is 2.50, ranking in quartile Q3 of Web of Science (SCIE).

Is Drugs in Research & Development indexed in Web of Science or Scopus?

Yes, Drugs in Research & Development is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.918 (Q2) and an H-index of 58.

Who publishes Drugs in Research & Development and what is the Article Processing Charge (APC)?

Drugs in Research & Development is published by Springer International Publishing. The estimated Article Processing Charge (APC) is approximately $3,141 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Drugs in Research & Development?

The official ISO-4 abbreviation of Drugs in Research & Development is "DRUGS R&D" with common acronym "drda". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #5,607Gold OA

Drugs in Research & Development

Acronym:drda

•

Abbreviation (ISO):DRUGS R&D

•

Identifier (ISSN):1174-5886(Print)/1179-6901(Online)

•

Publisher:Springer International Publishing

Official Website Submission Portal Compare

Clarivate IF (2026)

2.5↑ +0.4

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Drugs in Research & Development

WoS Q3

Annual Impact Factor Metric

Current (2026):2.5

Scopus SJR & RankScopus Q2

0.918

#5,607

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

58 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate4.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

36articles/year

100% Gold OA•93.75% Original Research

Aims & Scope

Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy. The Journal includes: Clinical research on new and established drugs; Preclinical research of direct relevance to clinical drug development; Short communications and case study reports that meet the above criteria will also be considered; Reviews may also be considered.

Topics Covered (Recognized by AI)

Medicine98.9%Biology73.2%Internal medicine64.7%Pharmacology51.3%Chemistry43.1%Genetics37.7%Biochemistry34%Pathology33.3%Psychology32.5%Endocrinology28.6%Psychiatry28.2%Surgery23.6%Bioinformatics23.4%

Primary Research Areas

Pharmacology Toxicology and Pharmaceutics

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank205/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank211/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	205/356	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	211/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.5

Articles / Year15

Total Citations10

2025

IF2.1

Articles / Year31

Total Citations50

2024

IF2.2

Articles / Year49

Total Citations242

2023

IF3

Articles / Year38

Total Citations316

2022

IF2.594

Articles / Year36

Total Citations264

Year	Impact Factor	Articles / Year	Total Citations
2026	2.5	15	10
2025	2.1	31	50
2024	2.2	49	242
2023	3	38	316
2022	2.594	36	264
2021	0	41	538
2020	0	42	949
2019	—	34	728
2018	—	33	530
2017	—	61	1,762
2016	—	45	1,657
2015	—	40	1,766

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,607Scopus Q2SCImago Profile

Scopus Coverage:1999, 2002-2008, 2010-2025

•

Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.918

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.68

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,141 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations291

3-Year Documents119

Citable Documents117

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate52.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drugs in Research & Development (acronym: drda, abbr: DRUGS R&D, ISSN: 1174-5886) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Springer International Publishing in New Zealand since 1999. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.918 (Q2), an H-index of 58.

The journal enforces rigorous peer evaluation with a publication frequency of 4 issues a year, 2010-, an annual output of approximately 36 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,141 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.